Deletion of the lipid kinase PIKfyve in Kras-driven pancreatic genetically engineered mouse model

被引：0
|
作者：
Yee, Sarah N.
Jiang, Xia
Cheng, Caleb
Korkaya, Ahmet
Mannan, Rahul
Mehra, Rohit
Qiao, Yuanyuan
Chinnaiyan, Arul M.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4323
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cellular 8-oxodGTPase activity as a novel target in KRAS-driven pancreatic cancer
    Mateo-Victoriano, Beatriz
    Zhang, Ling
    Samaranayake, Govindi
    Due, Cassie
    Troccoli, Clara
    Zaias, Julia
    Nagathihalli, Nagaraj
    Mohsen, Michael
    Kool, Eric
    Rai, Priyamvada
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 192
  • [32] Function for TRP1 in a model of Kras-driven lung cancer
    Ritzmann, F.
    Weichert, C.
    Kamyschnikow, A.
    Bals, R.
    Beisswenger, C.
    PNEUMOLOGIE, 2022, 76 : S13 - S13
  • [33] Regulatory T-cell depletion promotes oncogenic Kras-driven pancreatic carcinogenesis
    Zhang, Yaqing
    Lazarus, Jenny
    Steele, Nina
    Yan, Wei
    Lee, Ho-Joon
    Halbrook, Christopher J.
    Menjivar, Rosa
    Kemp, Samantha B.
    Sirihorachai, Veerin
    Carpenter, Eileen S.
    Nevison, Anna C.
    Vinta, Alekya
    Anderson, Michelle A.
    Crawford, Howard C.
    Lyssiotis, Costas A.
    Frankel, Timothy L.
    Bednar, Filip
    di Magliano, Marina Pasca
    CANCER RESEARCH, 2019, 79 (24)
  • [34] A KRAS P53 P16 Genetically Engineered Mouse Model Demonstrates Robust Onset and Penetrance of Pancreatic Ductal Adenocarcinoma
    Schmidt, B.
    Herrera, G.
    Yeh, J.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S14 - S15
  • [35] Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer
    Sangrador, Irene
    Molero, Xavier
    Campbell, Fiona
    Franch-Exposito, Sebastia
    Rovira-Rigau, Maria
    Samper, Esther
    Dominguez-Fraile, Manuel
    Fillat, Cristina
    Castells, Antoni
    Vaquero, Eva C.
    CANCER RESEARCH, 2018, 78 (10) : 2624 - 2637
  • [36] Leukemia inhibitory factor fosters tumor growth in KRAS-driven pancreatic ductal adenocarcinoma
    Miller-Phillips, Lisa
    Hanafi, Imene Boukhalfa
    Umetsu, Sarah
    Olshen, Adam
    Roy, Ritu
    Kiemen, Ashley
    Wang, Man-Tzu
    Collisson, Eric
    CANCER RESEARCH, 2024, 84 (02)
  • [37] Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression
    Court, Helen
    Amoyel, Marc
    Hackman, Michael
    Lee, Kyoung Eun
    Xu, Ruliang
    Miller, George
    Bar-Sagi, Dafna
    Bach, Erika A.
    Bergo, Martin O.
    Philips, Mark R.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11): : 4681 - 4694
  • [38] Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis
    Matsuura, Tetsuya
    Maru, Yoshiaki
    Izumiya, Masashi
    Hoshi, Daisuke
    Kato, Shingo
    Ochiai, Masako
    Hori, Mika
    Yamamoto, Shogo
    Tatsuno, Kenji
    Imai, Toshio
    Aburatani, Hiroyuki
    Nakajima, Atsushi
    Hippo, Yoshitaka
    CARCINOGENESIS, 2020, 41 (04) : 490 - 501
  • [39] Dissecting TGF beta-induced lethal EMT in Kras-driven pancreatic cancer
    Su, Jie
    CANCER RESEARCH, 2017, 77
  • [40] THE ROLE OF PRRX1 IN REGULATING KRAS-DRIVEN PANCREATIC ACINAR TO DUCTAL METAPLASIA
    Li, Alina L.
    Sugiura, Kensuke
    Suzuki, Kensuke
    Pitarresi, Jason R.
    Chiarella, Anna
    Efe, Gizem
    Chandwani, Rohit
    Rustgi, Anil
    GASTROENTEROLOGY, 2022, 162 (07) : S912 - S912
12345